Complement-dependent proinflammatory properties of the Alzheimer's disease β-peptide

被引:224
作者
Bradt, BM
Kolb, WP
Cooper, NR
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Adv Res Technol Inc, San Diego, CA 92121 USA
关键词
Alzheimer's disease; amyloid; C3; complement; inflammation;
D O I
10.1084/jem.188.3.431
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Large numbers of neuritic plaques (NP), largely composed of a fibrillar insoluble form of the beta-amyloid peptide (AP), are found in the hippocampus and neocortex of Alzheimer's disease (AD) patients in association with damaged neuronal processes, increased numbers of activated astrocytes and microglia, and several proteins including the components of the proinflammatory complement system. These studies address the hypothesis that the activated complement system mediates the cellular changes that surround fibrillar A beta deposits in NP. We report that A beta peptides directly and independently activate the alternative complement pathway as well as the classical complement pathway; trigger the formation of covalent, eater-linked complexes of A beta with activation products of the third complement component (C3); generate the cytokine-like C5a complement-activation fragment; and mediate formation of the proinflammatory C5b-9 membrane attack complex, in functionally active form able to insert into and permeabilize the membrane of neuronal precursor cells. These findings provide inflammation-based mechanisms to account for the presence of complement components in NP in association with damaged neurons and increased numbers of activated glial cells, and they have potential implications for the therapy of AD.
引用
收藏
页码:431 / 438
页数:8
相关论文
共 35 条
[1]   INFLAMMATORY CYTOKINES WITHIN THE CENTRAL-NERVOUS-SYSTEM - SOURCES, FUNCTION, AND MECHANISM OF ACTION [J].
BENVENISTE, EN .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (01) :C1-C16
[2]   beta-amyloid peptides initiate the complement cascade without producing a comparable effect on the terminal pathway in vitro [J].
Cadman, ED ;
Puttfarcken, PS .
EXPERIMENTAL NEUROLOGY, 1997, 146 (02) :388-394
[3]  
Chen S, 1996, NEUROBIOL AGING, V17, P781
[4]  
COOPER NR, 1998, IN PRESS INFLAMMATIO
[5]  
DYRKS T, 1992, J BIOL CHEM, V267, P18210
[6]   IMMUNOGLOBULINS AND COMPLEMENT FACTORS IN SENILE PLAQUES - AN IMMUNOPEROXIDASE STUDY [J].
EIKELENBOOM, P ;
STAM, FC .
ACTA NEUROPATHOLOGICA, 1982, 57 (2-3) :239-242
[7]   SOLUBILIZATION OF IMMUNE PRECIPITATES BY 6 ISOLATED ALTERNATIVE PATHWAY PROTEINS [J].
FUJITA, T ;
TAKATA, Y ;
TAMURA, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (06) :1743-1751
[8]   THE BINDING OF COMPLEMENT COMPONENT-C3 TO ANTIBODY-ANTIGEN AGGREGATES AFTER ACTIVATION OF THE ALTERNATIVE PATHWAY IN HUMAN-SERUM [J].
GADD, KJ ;
REID, KBM .
BIOCHEMICAL JOURNAL, 1981, 195 (02) :471-480
[9]  
GRIFFIN WST, 1995, J NEUROPATH EXP NEUR, V54, P276
[10]   DIRECT EVIDENCE OF OXIDATIVE INJURY PRODUCED BY THE ALZHEIMERS BETA-AMYLOID PEPTIDE (1-40) IN CULTURED HIPPOCAMPAL-NEURONS [J].
HARRIS, ME ;
HENSLEY, K ;
BUTTERFIELD, DA ;
LEEDLE, RA ;
CARNEY, JM .
EXPERIMENTAL NEUROLOGY, 1995, 131 (02) :193-202